CLX Paid Holders $3.8 billion While The Stock Went Nowhere

Clorox showered its owners with cash while the stock price sank. Here is the honest accounting of what that trade-off actually delivered, and what it means now.

Over the last five years, Clorox (CLX) has handed its shareholders $3.8 billion in cash, an amount equal to 33% of the company’s entire market value today. But for a business whose stock now trades around $96.32 a share, some 40% below its two-year high, that large payout has been paired with deeply disappointing returns. The company returned a fortune to its owners while the stock itself lagged badly.

How did a household products business generate that much cash?

The machine runs on the steady, if unspectacular, demand for consumer staples. Clorox’s $6.76 billion in annual revenue comes from brands found in millions of homes, with its cleaning business continuing to be an “area of strength,” according to management. That reliable stream of sales funded the large capital return, which was split between $2.9 billion in dividends and another $913 million in share repurchases over the five years.

This level of payout is significant. While the median S&P 500 company returned $5.7 billion over the same timeframe, that represented a smaller 16.6% of its market value. Clorox’s commitment to returning cash is, by this measure, unusually high, reflecting a mature business generating more cash than it needs for immediate reinvestment.

If the checks were so generous, why did the stock fall so far behind?

While Clorox was mailing checks, its stock price delivered a -37% return over the last five years. During that same period, the S&P 500 returned +82%. The cash payouts, while substantial, were not nearly enough to close that gap. This performance has led some to ask if this is a stock that lags the market for fundamental reasons. For investors seeking broader exposure to this defensive sector, a consumer staples ETF like XLP offers a diversified alternative.

The honest catch is that the stock’s weakness is rooted in the business itself, not only in market sentiment. Management has been candid that the “pace of improvement has been slower than we expected in some businesses.” Key initiatives, like the reinvention of its Fresh Step litter brand, have been “bumpier” than anticipated. The company has secured distribution gains, but then struggled with execution, finding products “shelved in a different place than we had expected.” This isn’t a sign of discipline; it’s a business struggling to execute its own turnaround, starving the stock of a growth story.

What single factor determines if the payout is sustainable?

For the cash to keep flowing, Clorox must stabilize its operations and protect its margins from new pressures. The company is now facing an estimated headwind of “between $20 million and $25 million” in the fourth quarter alone from higher oil prices. This directly threatens the profitability that funds the dividend and buybacks. Management’s focus is now squarely on “sharpening execution” to offset these challenges.

The company has already lowered its outlook, guiding for Adjusted EPS in a range of $5.45 to $5.65 for the fiscal year, and the August 3 earnings report will reveal if its operational fixes are enough to keep the cash machine from sputtering.

To see where this record sits against the market’s other great cash returners, our Buybacks & Dividends ranking holds the full league table.

Even The Most Generous Payer Is Still One Stock

Generous buybacks and dividends reward holders, and even the most generous payer is still one company. How much damage any single position could do to your net worth is a question with a precise answer. The Trefis Wealth team computes it for investors professionally, with the same rules-based systematic discipline that runs our High Quality Portfolio. Request a free vulnerability audit of your biggest positions.